Icad Total Current Liabilities vs Other Current Liab Analysis

ICAD Stock  USD 1.82  0.04  2.15%   
Icad financial indicator trend analysis is infinitely more than just investigating icad inc recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether icad inc is a good investment. Please check the relationship between Icad Total Current Liabilities and its Other Current Liab accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in icad inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Total Current Liabilities vs Other Current Liab

Total Current Liabilities vs Other Current Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of icad inc Total Current Liabilities account and Other Current Liab. At this time, the significance of the direction appears to have strong relationship.
The correlation between Icad's Total Current Liabilities and Other Current Liab is 0.71. Overlapping area represents the amount of variation of Total Current Liabilities that can explain the historical movement of Other Current Liab in the same time period over historical financial statements of icad inc, assuming nothing else is changed. The correlation between historical values of Icad's Total Current Liabilities and Other Current Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Liabilities of icad inc are associated (or correlated) with its Other Current Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Current Liab has no effect on the direction of Total Current Liabilities i.e., Icad's Total Current Liabilities and Other Current Liab go up and down completely randomly.

Correlation Coefficient

0.71
Relationship DirectionPositive 
Relationship StrengthSignificant

Total Current Liabilities

Total Current Liabilities is an item on Icad balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of icad inc are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Other Current Liab

Most indicators from Icad's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into icad inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in icad inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
The current year's Selling General Administrative is expected to grow to about 9.6 M, whereas Tax Provision is projected to grow to (97.8 K).
 2021 2022 2023 2024 (projected)
Total Operating Expenses35.0M33.7M22.2M20.0M
Cost Of Revenue9.4M8.1M2.8M2.6M

Icad fundamental ratios Correlations

0.260.280.750.870.6-0.44-0.180.70.740.150.70.550.220.070.160.190.340.450.470.690.570.480.080.120.11
0.260.360.61-0.190.040.640.22-0.160.42-0.07-0.160.21-0.340.84-0.26-0.17-0.270.85-0.26-0.070.520.880.160.090.07
0.280.360.710.040.170.08-0.10.180.060.030.180.570.030.20.260.360.080.490.120.350.040.190.320.0-0.03
0.750.610.710.390.370.06-0.110.40.55-0.070.40.690.030.450.20.220.160.820.180.520.460.610.14-0.09-0.12
0.87-0.190.040.390.59-0.76-0.280.720.570.20.720.380.39-0.410.240.240.47-0.060.60.670.380.11-0.010.310.32
0.60.040.170.370.59-0.43-0.270.580.27-0.040.580.510.35-0.080.410.320.350.150.660.60.110.20.150.150.15
-0.440.640.080.06-0.76-0.430.56-0.80.05-0.36-0.8-0.35-0.690.72-0.3-0.5-0.680.48-0.72-0.70.260.470.04-0.23-0.25
-0.180.22-0.1-0.11-0.28-0.270.56-0.630.32-0.09-0.63-0.62-0.980.36-0.17-0.66-0.970.14-0.46-0.610.570.410.5-0.18-0.2
0.7-0.160.180.40.720.58-0.8-0.630.10.341.00.70.7-0.210.20.560.720.10.730.93-0.13-0.08-0.010.00.01
0.740.420.060.550.570.270.050.320.1-0.040.1-0.02-0.280.22-0.21-0.41-0.140.45-0.060.020.930.71-0.010.180.16
0.15-0.070.03-0.070.2-0.04-0.36-0.090.34-0.040.340.030.16-0.05-0.090.210.11-0.070.180.26-0.02-0.120.430.240.25
0.7-0.160.180.40.720.58-0.8-0.631.00.10.340.70.7-0.210.20.560.720.10.730.93-0.13-0.08-0.010.00.01
0.550.210.570.690.380.51-0.35-0.620.7-0.020.030.70.560.090.350.620.610.420.470.84-0.170.09-0.01-0.07-0.07
0.22-0.340.030.030.390.35-0.69-0.980.7-0.280.160.70.56-0.460.170.640.98-0.240.550.63-0.56-0.45-0.460.210.24
0.070.840.20.45-0.41-0.080.720.36-0.210.22-0.05-0.210.09-0.46-0.27-0.24-0.430.88-0.34-0.140.360.70.23-0.4-0.42
0.16-0.260.260.20.240.41-0.3-0.170.2-0.21-0.090.20.350.17-0.270.680.16-0.110.560.46-0.21-0.230.40.040.01
0.19-0.170.360.220.240.32-0.5-0.660.56-0.410.210.560.620.64-0.240.680.61-0.060.750.72-0.49-0.320.230.180.16
0.34-0.270.080.160.470.35-0.68-0.970.72-0.140.110.720.610.98-0.430.160.61-0.160.510.66-0.44-0.36-0.510.220.24
0.450.850.490.82-0.060.150.480.140.10.45-0.070.10.42-0.240.88-0.11-0.06-0.16-0.130.180.470.770.18-0.31-0.34
0.47-0.260.120.180.60.66-0.72-0.460.73-0.060.180.730.470.55-0.340.560.750.51-0.130.77-0.17-0.110.260.210.22
0.69-0.070.350.520.670.6-0.7-0.610.930.020.260.930.840.63-0.140.460.720.660.180.77-0.15-0.040.14-0.010.0
0.570.520.040.460.380.110.260.57-0.130.93-0.02-0.13-0.17-0.560.36-0.21-0.49-0.440.47-0.17-0.150.790.190.160.14
0.480.880.190.610.110.20.470.41-0.080.71-0.12-0.080.09-0.450.7-0.23-0.32-0.360.77-0.11-0.040.790.220.120.1
0.080.160.320.14-0.010.150.040.5-0.01-0.010.43-0.01-0.01-0.460.230.40.23-0.510.180.260.140.190.220.030.0
0.120.090.0-0.090.310.15-0.23-0.180.00.180.240.0-0.070.21-0.40.040.180.22-0.310.21-0.010.160.120.031.0
0.110.07-0.03-0.120.320.15-0.25-0.20.010.160.250.01-0.070.24-0.420.010.160.24-0.340.220.00.140.10.01.0
Click cells to compare fundamentals

Icad Account Relationship Matchups

Icad fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets41.7M55.6M62.2M51.7M41.4M43.2M
Short Long Term Debt Total22.5M8.8M1.2M3.4M461K438.0K
Other Current Liab6.6M7.0M5.6M4.7M2.4M3.2M
Total Current Liabilities18.8M16.8M15.0M13.5M6.7M9.3M
Total Stockholder Equity5.1M30.5M46.5M34.9M33.4M28.7M
Property Plant And Equipment Net3.0M2.5M1.9M4.4M2.3M2.1M
Net Debt7.2M(18.4M)(33.1M)(17.9M)(21.2M)(20.1M)
Retained Earnings(224.3M)(241.9M)(253.2M)(266.8M)(271.7M)(258.1M)
Cash15.3M27.2M34.3M21.3M21.7M22.8M
Non Current Assets Total12.6M13.3M11.9M13.5M11.7M23.3M
Non Currrent Assets Other50K1.5M899K54K692.0K416.7K
Cash And Short Term Investments15.3M27.2M34.3M21.3M21.7M22.8M
Net Receivables9.8M10.0M8.9M8.9M6.4M5.7M
Common Stock Shares Outstanding18.4M22.1M24.8M25.2M25.6M26.9M
Liabilities And Stockholders Equity41.7M55.6M62.2M51.7M41.4M43.2M
Non Current Liabilities Total17.8M8.3M712K3.4M1.3M1.2M
Inventory2.6M3.1M4.2M5.4M917K871.2K
Other Current Assets1.5M1.9M3.0M2.6M699K681.0K
Other Stockholder Equity229.2M272.2M299.4M301.5M304.8M320.1M
Total Liab36.7M25.1M15.7M16.8M8.0M14.5M
Property Plant And Equipment Gross3.0M2.5M8.0M6.6M3.3M2.3M
Total Current Assets29.2M42.3M50.3M38.2M29.7M19.9M
Intangible Assets1.2M889K683K482K148K140.6K
Short Term Debt5.0M726K889K582K188K178.6K
Accounts Payable2.0M2.9M2.8M2.0M712K676.4K
Common Stock Total Equity171K196K236K253K227.7K216.1K
Common Stock196K236K253K254K265K215.4K
Other Assets50K3.3M899K185K1.00.95
Long Term Debt5.1M4.3M2.0M7.0M8.0M4.3M
Property Plant Equipment551K2.5M1.9M4.4M5.1M5.4M
Current Deferred Revenue5.2M6.1M5.7M6.2M3.4M4.6M
Other Liab361K359K271K446K401.4K381.3K
Net Tangible Assets(4.5M)21.3M37.5M26.1M23.5M16.2M
Retained Earnings Total Equity(201.9M)(210.8M)(224.3M)(253.2M)(227.9M)(216.5M)
Capital Surpluse217.4M218.9M230.6M300.9M346.0M236.9M
Deferred Long Term Liab520K334K359K446K401.4K653.4K
Non Current Liabilities Other119K7.0M13.6M266K305.9K290.6K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether icad inc is a strong investment it is important to analyze Icad's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Icad's future performance. For an informed investment choice regarding Icad Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in icad inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Icad. If investors know Icad will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Icad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.16)
Revenue Per Share
0.718
Quarterly Revenue Growth
0.206
Return On Assets
(0.08)
Return On Equity
(0.15)
The market value of icad inc is measured differently than its book value, which is the value of Icad that is recorded on the company's balance sheet. Investors also form their own opinion of Icad's value that differs from its market value or its book value, called intrinsic value, which is Icad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Icad's market value can be influenced by many factors that don't directly affect Icad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Icad's value and its price as these two are different measures arrived at by different means. Investors typically determine if Icad is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Icad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.